-
The Greening of Pharma
things catalytically, we can achieve even higher levels of efficiency. Volante notes that in the last five to 10 years, many pharma companies have gone away from an internal catalysis development focus, having. Pharmaceutical Environmental Regulations | The Greening of Pharma | Pharmaceutical
-
The Greening of Pharma
the common issues all members face and how we can work together precompetitively and noncompetitively to solve them.? More specifically, Cue says, the two big issues the Roundtable is tackling are 1) the development of metrics that would help pharma companies answer the question, How do we measure how
-
Big Pharma's Black Hole
Operational Excellence & Lean Six Sigma When Small Biotech Met Big Pharma Mea Culpa by a Big Pharma CEO Mega Mergers Can't Cure the Pharmaceutical Industry Big Pharma Eyes Healthy Earnings Calls Mount for Rethink of "Big Pharma" Model The Case for Generic and Follow-On Biologics Pharmaceutical
-
Pharma s RFID Exhaustion
for a government-sponsored pharma e-pedigree pilot.So
is there a sort of "exhaustion" setting in concerning RFID? Absolutely. Companies are tired of the hype and hysteria and are increasingly realizing that they need to start seriously investigating or implementing the technology. To cast your vote, log
-
Will Pharma Wear the Energy Star?
performance leaders. EPA and Argonne National Laboratories are developing the pharma EPIs, based on drug manufacturing plant data collected by the U.S. Census Bureau and Department of Energy. The model is in its early draft form, and is under review by energy professionals from participating
-
Philadelphia Fetes Pharma
to PharmaMedDevice, Interphex will be co-located with Biotechnica America. The result of a partnership between the producers of Interphex and Europe s Biotechnica show, Biotechnica America fills in a key piece of the contemporary pharma industry puzzle in order to broaden Interphex s appeal and relevance
-
Pharma's Global Hunt for Talent
., Gereffi et al, Where the Engineers Are, Issues in Science and Technology, University of Texas, 2005. 9. Tucker, S. A Bidding War Makes for Crazy Salaries Across Asia, Financial Times Germany, May 18, 2007. Bullish on Asia Despite the risks of setting up operations offshore, most pharma
-
Benchmarking Pharma s Use of MES
to the plant floor. Quite a few firms, across all industries, have not yet made this vital connection, the study suggests, hampering their ability to make the best decisions in real time. However, results of the survey also suggests that more manufacturers, pharma included, are taking the steps